Metagenomi, Inc. Common Stock
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Metagenomi, Inc. Common Stock generated cash of -$91,409,000, which is less than the previous year. Cash used in financing activities reached the amount of $1,012,000 last year. Net change in cash is therefore -$44,663,000.
Cash Flow
| 2022 | 29.72M | -122.2M | 239.59M |
|---|---|---|---|
| 2023 | -91.40M | 45.73M | 1.01M |
MGX Cash Flow Statement (2022 – 2023)
| 2023 | 2022 | |
|---|---|---|
Cash at beginning of period | 190.51M | 43.39M |
Operating activities | ||
Net income | -68.25M | -43.59M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 4.20M | 1.73M |
Stock-based compensation expense | 6.92M | 1.96M |
| Deferred income tax benefit | 6.92M | 1.96M |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | -2.45M | -1.27M |
Inventories | 0 | 0 |
Accounts payable | -84K | 721K |
Cash generated by operating activities | -91.40M | 29.72M |
Investing activities | ||
Purchases Of Investments | -208.09M | -214.85M |
Investments In Property Plant And Equipment | -9.81M | -13.97M |
Acquisitions Net | 0 | 0 |
Cash generated by investing activities | 45.73M | -122.2M |
Financing activities | ||
Common Stock Issued | 1.01M | 239.59M |
Payments for dividends | 0 | 0 |
Repurchases of common stock | 0 | 0 |
Repayments of term debt | 0 | 0 |
Cash used in financing activities | 1.01M | 239.59M |
Net Change In Cash | -44.66M | 147.11M |
Cash at end of period | 145.85M | 190.51M |